Back to Agenda
Break Out Sessions 2A: Complex Innovative Design Trials
Session Chair(s)
Daniel Millar, MBA
Senior Director, Strategic Business Transformation, Johnson & Johnson, United States
Complex Innovative Design Trials
Speaker(s)
Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project
Cecile Spiertz, MSc
, Netherlands
Protocol Development for Master Protocol Studies – Balancing Structure with Function
Jonathan Mackinnon, PhD
Associate Director, Medical Writing Services, Parexel International, Spain
Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers
Christine Fletcher, MSc
VP/Head, Speciality and Primary Care Statistics, GlaxoSmithKline, United Kingdom
Panel discussion with Q&A
Olga Kholmanskikh Van Criekingen, MD, PhD
Clinical assessor, Federal Agency for Medicines and Health Products, Belgium
Have an account?